Company Is Honored for Its Commitment

Published Online: Thursday, July 1, 2004

On May 8, 2004, Novo Nordisk received the Angel Award for its dedication to improving the lives of individuals with diabetes and its unwavering focus on treating and preventing diabetes worldwide. The award was presented at the Los Angeles Chapter of the Juvenile Diabetes Research Foundation's (JDRF) annual gala benefiting the Stem Cell Research Fund.

Along with its work with the JDRF, Novo Nordisk is active in a number of initiatives as part of the company's dedication to social responsibility. The company recently launched the Diabetes Aware campaign with the Entertainment Industry Foundation to educate Americans about the importance of detection, monitoring, and proper management of this chronic, progressive disease.



Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$
VSEO N/A